Cytoskeletal organization proteins

Cytoskeletal organization proteins represent a broad class of structural and regulatory molecules, including actin, tubulin, and intermediate filaments, along with their associated motor proteins and signaling regulators. These proteins are fundamental to cellular life, governing cell shape, mechanical stability, intracellular transport, and the orchestration of mitosis and cytokinesis (StatPearls, 2023). In pathological states, dysregulation of these proteins facilitates cancer cell invasion, contributes to the formation of protein aggregates in neurodegenerative diseases like Alzheimer's, and underlies various cardiomyopathies (Nature Reviews Molecular Cell Biology, 2011). Pharmacological intervention typically involves small molecules that either stabilize or destabilize polymer assembly, such as taxanes and vinca alkaloids, or inhibit regulatory enzymes like Rho-associated protein kinase (ROCK) (Journal of Hematology & Oncology, 2022). While highly effective in treating malignancies and certain ocular conditions, the ubiquitous nature of these proteins often leads to significant side effects, most notably peripheral neuropathy and myelosuppression. Biomarkers such as Tau protein and specific cytokeratin fragments are used clinically to monitor disease progression and response to therapy in neurodegeneration and oncology (UniProt, 2024).

Other names

Cytoskeletal proteinsCytoskeleton-associated proteinsStructural proteins of the cytoskeleton

Microtubule stabilization, microtubule destabilization, and Rho-associated protein kinase (ROCK) inhibition.